Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - GROSS PROFIT
Gross Profit SMMT - Summit Therapeutics Inc.
-2.05 M
LAST VALUE
-46.06%
2 YEAR CAGR
-0.72%
5 YEAR CAGR
-6.65%
10 YEAR CAGR